{
  "folder": "IC-325",
  "content": "{{knowledge objective\n|Identifiant=OIC-325-02-A\n|Item_parent=Identification and management of risks associated with medicines and biomaterials, iatrogenic risk, medicinal errors (see items 4 and 5)\n|Item_parent_short=Identification and management of risks associated with medicines and biomaterials, iatrogenic risk, medication errors (see items 4 and 5)\n|Rank=A\n|Title=Understand the issues concerning the risks associated with medicines and biomaterials.\n|Description=None\n|Section=Definition\n|Contributors=Marie Briet\n|Order=2}}\n\n== There are two types of risk associated with medicines ==\n\n=== Individual issues: ===\n\n* at patient level to ensure proper use of medicines and appropriate management.\n\n=== Public health issues: ===\n\n* The need for a system for monitoring, detecting and analysing signals in real life\n* To fine-tune information and regulatory decisions relating to medicines\n\n<br /><br />",
  "question": {
    "properties": {
      "question": "Which of the following is NOT a public health issue associated with the risks of medicines and biomaterials?",
      "option_a": "Implementation of a system for monitoring adverse drug reactions",
      "option_b": "Analysis of signals in real life to improve regulatory decisions",
      "option_c": "Ensuring proper use of medicines at the individual patient level",
      "option_d": "Fine-tuning information based on public health data",
      "correct_option": "C"
    },
    "required": [
      "question",
      "option_a",
      "option_b",
      "option_c",
      "option_d",
      "correct_option"
    ]
  }
}